Impact of levodopa treatment in the voice pattern of Parkinson’s disease patients: a systematic review and meta-analysis

Detalhes bibliográficos
Autor(a) principal: Pinho,Patrícia
Data de Publicação: 2018
Outros Autores: Monteiro,Larissa, Soares,Maria Francisca de Paula, Tourinho,Lorena, Melo,Ailton, Nóbrega,Ana Caline
Tipo de documento: Artigo
Idioma: eng
Título da fonte: CoDAS
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2317-17822018000500602
Resumo: Abstract Purpose Investigate the association between levodopa therapy and vocal characteristics in Parkinson’s disease patients. Search strategy Studies published at MEDLINE, LILACS, and SciELO, from 1960 to December 2016. A systematic review and meta-analysis was performed using the following keywords: Parkinson’s disease; levodopa; L-dopa; voice; speech disorders; dysphonia; dysarthria. After analyzing titles and abstracts, two independent reviewers selected all clinical trials that met the eligibility criteria and selected the articles and the data recorded in a previously standardized table. Selection criteria Trials published in English between 1960 and December 2016 individuals with clinical diagnosis of Parkinson’s disease; use of levodopa therapy in stable doses; acoustic analysis combined or not with auditory-perceptual analysis to evaluate the vocal parameters under investigation. Data analysis The following vocal parameters were analyzed: fundamental frequency (F 0), jitter, and vocal intensity. Standardized mean differences (SMD) were calculated using the Comprehensive Meta-analysis V2 software. Results Nine articles met the eligibility criteria and were selected, with a total of 119 individuals. From these, six articles with 83 individuals were included in the meta-analysis. During the levodopa therapy “on” state, modifications in F 0 (SMD=0.39; 95% CI - 0.21-0.57) and jitter (SMD=0.23; 95% CI - 0.02-0.45) were observed. Vocal intensity was not affected (SMD=0.09; 95% CI - 0.22-0.39) by levodopa ingestion. Data of the included studies were controversial in the auditory-perceptual analysis of voice. Conclusion Levodopa therapy modifies F0 and jitter. No changes in vocal intensity were observed in either the “on” or “off” states of levodopa therapy.
id SBFA-1_79762bbdb8e884ba9890723d197d102e
oai_identifier_str oai:scielo:S2317-17822018000500602
network_acronym_str SBFA-1
network_name_str CoDAS
repository_id_str
spelling Impact of levodopa treatment in the voice pattern of Parkinson’s disease patients: a systematic review and meta-analysisLevodopaParkinson’s DiseaseSystematic ReviewMeta-analysisVoiceAbstract Purpose Investigate the association between levodopa therapy and vocal characteristics in Parkinson’s disease patients. Search strategy Studies published at MEDLINE, LILACS, and SciELO, from 1960 to December 2016. A systematic review and meta-analysis was performed using the following keywords: Parkinson’s disease; levodopa; L-dopa; voice; speech disorders; dysphonia; dysarthria. After analyzing titles and abstracts, two independent reviewers selected all clinical trials that met the eligibility criteria and selected the articles and the data recorded in a previously standardized table. Selection criteria Trials published in English between 1960 and December 2016 individuals with clinical diagnosis of Parkinson’s disease; use of levodopa therapy in stable doses; acoustic analysis combined or not with auditory-perceptual analysis to evaluate the vocal parameters under investigation. Data analysis The following vocal parameters were analyzed: fundamental frequency (F 0), jitter, and vocal intensity. Standardized mean differences (SMD) were calculated using the Comprehensive Meta-analysis V2 software. Results Nine articles met the eligibility criteria and were selected, with a total of 119 individuals. From these, six articles with 83 individuals were included in the meta-analysis. During the levodopa therapy “on” state, modifications in F 0 (SMD=0.39; 95% CI - 0.21-0.57) and jitter (SMD=0.23; 95% CI - 0.02-0.45) were observed. Vocal intensity was not affected (SMD=0.09; 95% CI - 0.22-0.39) by levodopa ingestion. Data of the included studies were controversial in the auditory-perceptual analysis of voice. Conclusion Levodopa therapy modifies F0 and jitter. No changes in vocal intensity were observed in either the “on” or “off” states of levodopa therapy.Sociedade Brasileira de Fonoaudiologia2018-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2317-17822018000500602CoDAS v.30 n.5 2018reponame:CoDASinstname:Sociedade Brasileira de Fonoaudiologia (SBFA)instacron:SBFA10.1590/2317-1782/20182017200info:eu-repo/semantics/openAccessPinho,PatríciaMonteiro,LarissaSoares,Maria Francisca de PaulaTourinho,LorenaMelo,AiltonNóbrega,Ana Calineeng2018-10-03T00:00:00Zoai:scielo:S2317-17822018000500602Revistahttps://www.codas.org.br/ONGhttps://old.scielo.br/oai/scielo-oai.phpcodas@editoracubo.com.br||revista@codas.org.br2317-17822317-1782opendoar:2018-10-03T00:00CoDAS - Sociedade Brasileira de Fonoaudiologia (SBFA)false
dc.title.none.fl_str_mv Impact of levodopa treatment in the voice pattern of Parkinson’s disease patients: a systematic review and meta-analysis
title Impact of levodopa treatment in the voice pattern of Parkinson’s disease patients: a systematic review and meta-analysis
spellingShingle Impact of levodopa treatment in the voice pattern of Parkinson’s disease patients: a systematic review and meta-analysis
Pinho,Patrícia
Levodopa
Parkinson’s Disease
Systematic Review
Meta-analysis
Voice
title_short Impact of levodopa treatment in the voice pattern of Parkinson’s disease patients: a systematic review and meta-analysis
title_full Impact of levodopa treatment in the voice pattern of Parkinson’s disease patients: a systematic review and meta-analysis
title_fullStr Impact of levodopa treatment in the voice pattern of Parkinson’s disease patients: a systematic review and meta-analysis
title_full_unstemmed Impact of levodopa treatment in the voice pattern of Parkinson’s disease patients: a systematic review and meta-analysis
title_sort Impact of levodopa treatment in the voice pattern of Parkinson’s disease patients: a systematic review and meta-analysis
author Pinho,Patrícia
author_facet Pinho,Patrícia
Monteiro,Larissa
Soares,Maria Francisca de Paula
Tourinho,Lorena
Melo,Ailton
Nóbrega,Ana Caline
author_role author
author2 Monteiro,Larissa
Soares,Maria Francisca de Paula
Tourinho,Lorena
Melo,Ailton
Nóbrega,Ana Caline
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Pinho,Patrícia
Monteiro,Larissa
Soares,Maria Francisca de Paula
Tourinho,Lorena
Melo,Ailton
Nóbrega,Ana Caline
dc.subject.por.fl_str_mv Levodopa
Parkinson’s Disease
Systematic Review
Meta-analysis
Voice
topic Levodopa
Parkinson’s Disease
Systematic Review
Meta-analysis
Voice
description Abstract Purpose Investigate the association between levodopa therapy and vocal characteristics in Parkinson’s disease patients. Search strategy Studies published at MEDLINE, LILACS, and SciELO, from 1960 to December 2016. A systematic review and meta-analysis was performed using the following keywords: Parkinson’s disease; levodopa; L-dopa; voice; speech disorders; dysphonia; dysarthria. After analyzing titles and abstracts, two independent reviewers selected all clinical trials that met the eligibility criteria and selected the articles and the data recorded in a previously standardized table. Selection criteria Trials published in English between 1960 and December 2016 individuals with clinical diagnosis of Parkinson’s disease; use of levodopa therapy in stable doses; acoustic analysis combined or not with auditory-perceptual analysis to evaluate the vocal parameters under investigation. Data analysis The following vocal parameters were analyzed: fundamental frequency (F 0), jitter, and vocal intensity. Standardized mean differences (SMD) were calculated using the Comprehensive Meta-analysis V2 software. Results Nine articles met the eligibility criteria and were selected, with a total of 119 individuals. From these, six articles with 83 individuals were included in the meta-analysis. During the levodopa therapy “on” state, modifications in F 0 (SMD=0.39; 95% CI - 0.21-0.57) and jitter (SMD=0.23; 95% CI - 0.02-0.45) were observed. Vocal intensity was not affected (SMD=0.09; 95% CI - 0.22-0.39) by levodopa ingestion. Data of the included studies were controversial in the auditory-perceptual analysis of voice. Conclusion Levodopa therapy modifies F0 and jitter. No changes in vocal intensity were observed in either the “on” or “off” states of levodopa therapy.
publishDate 2018
dc.date.none.fl_str_mv 2018-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2317-17822018000500602
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2317-17822018000500602
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/2317-1782/20182017200
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Fonoaudiologia
publisher.none.fl_str_mv Sociedade Brasileira de Fonoaudiologia
dc.source.none.fl_str_mv CoDAS v.30 n.5 2018
reponame:CoDAS
instname:Sociedade Brasileira de Fonoaudiologia (SBFA)
instacron:SBFA
instname_str Sociedade Brasileira de Fonoaudiologia (SBFA)
instacron_str SBFA
institution SBFA
reponame_str CoDAS
collection CoDAS
repository.name.fl_str_mv CoDAS - Sociedade Brasileira de Fonoaudiologia (SBFA)
repository.mail.fl_str_mv codas@editoracubo.com.br||revista@codas.org.br
_version_ 1752122442171547648